These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21444863)

  • 1. Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States.
    Drazer MW; Huo D; Schonberg MA; Razmaria A; Eggener SE
    J Clin Oncol; 2011 May; 29(13):1736-43. PubMed ID: 21444863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical center characteristics associated with PSA screening in elderly veterans with limited life expectancy.
    So C; Kirby KA; Mehta K; Hoffman RM; Powell AA; Freedland SJ; Sirovich B; Yano EM; Walter LC
    J Gen Intern Med; 2012 Jun; 27(6):653-60. PubMed ID: 22180196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinician Factors Associated With Prostate-Specific Antigen Screening in Older Veterans With Limited Life Expectancy.
    Tang VL; Shi Y; Fung K; Tan J; Espaldon R; Sudore R; Wong ML; Walter LC
    JAMA Intern Med; 2016 May; 176(5):654-61. PubMed ID: 27042937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.
    Drazer MW; Huo D; Eggener SE
    J Clin Oncol; 2015 Aug; 33(22):2416-23. PubMed ID: 26056181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.
    Drazer MW; Prasad SM; Huo D; Schonberg MA; Dale W; Szmulewitz RZ; Eggener SE
    Cancer; 2014 May; 120(10):1491-8. PubMed ID: 24523016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSA screening among elderly men with limited life expectancies.
    Walter LC; Bertenthal D; Lindquist K; Konety BR
    JAMA; 2006 Nov; 296(19):2336-42. PubMed ID: 17105796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer screening rates in individuals with different life expectancies.
    Royce TJ; Hendrix LH; Stokes WA; Allen IM; Chen RC
    JAMA Intern Med; 2014 Oct; 174(10):1558-65. PubMed ID: 25133746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate Specific Antigen Screening on a Nationwide Level: Featuring the Contribution of Race and Life Expectancy in Decision Making.
    Dalela D; Corsi NJ; Bronkema C; Sood A; Arora S; Majdalany SE; Butaney M; Jamil M; Li P; Palma-Zamora I; Rakic N; Kovacevic N; Jeong W; Menon M; Rogers CG; Schonberg MA; Abdollah F
    Clin Genitourin Cancer; 2024 Apr; 22(2):269-280.e2. PubMed ID: 38233279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-Specific Antigen Testing Initiation and Shared Decision-Making: Findings from the 2000 and 2015 National Health Interview Surveys.
    Li J; Ding H; Richards TB; Martin I; Kobrin S; Marcus PM
    J Am Board Fam Med; 2018; 31(4):658-662. PubMed ID: 29986994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial differences in prostate-specific antigen-based prostate cancer screening: State-by-state and region-by-region analyses.
    Jindal T; Kachroo N; Sammon J; Dalela D; Sood A; Vetterlein MW; Karabon P; Jeong W; Menon M; Trinh QD; Abdollah F
    Urol Oncol; 2017 Jul; 35(7):460.e9-460.e20. PubMed ID: 28256311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Association of County-level Prostate-specific Antigen Screening with Metastatic Prostate Cancer and Prostate Cancer Mortality.
    Stone BV; Labban M; Beatrici E; Filipas DK; D'Amico AV; Lipsitz SR; Choueiri TK; Kibel AS; Cole AP; Iyer HS; Trinh QD
    Eur Urol Oncol; 2024 Jun; 7(3):563-569. PubMed ID: 38155059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen testing after the US Preventive Services Task Force recommendation: a population-based analysis of electronic health data.
    Frendl DM; Epstein MM; Fouayzi H; Krajenta R; Rybicki BA; Sokoloff MH
    Cancer Causes Control; 2020 Sep; 31(9):861-867. PubMed ID: 32556947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen (PSA) screening and follow-up investigations in Māori and non-Māori men in New Zealand.
    Obertová Z; Scott N; Brown C; Hodgson F; Stewart A; Holmes M; Lawrenson R
    BMC Fam Pract; 2014 Aug; 15():145. PubMed ID: 25154420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary care providers' perspectives on discontinuing prostate cancer screening.
    Pollack CE; Platz EA; Bhavsar NA; Noronha G; Green GE; Chen S; Carter HB
    Cancer; 2012 Nov; 118(22):5518-24. PubMed ID: 22517310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downstream tests, treatments, and annual direct payments in older men cared for by primary care providers with high or low prostate-specific antigen screening rates using 100 percent Texas U.S. Medicare public insurance claims data: a retrospective cohort study.
    Zanwar P; Lin YL; Kuo YF; Goodwin JS
    BMC Health Serv Res; 2016 Jan; 16():17. PubMed ID: 26772175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists.
    Fowler FJ; Bin L; Collins MM; Roberts RG; Oesterling JE; Wasson JH; Barry MJ
    Am J Med; 1998 Jun; 104(6):526-32. PubMed ID: 9674714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate carcinoma among men with human immunodeficiency virus infection.
    Crum NF; Spencer CR; Amling CL
    Cancer; 2004 Jul; 101(2):294-9. PubMed ID: 15241826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the prostate-specific antigen test among men aged 75 years or older in the United States: 2006 Behavioral Risk Factor Surveillance System.
    Li J; Zhao G; Pollack LA; Smith JL; Joseph DA
    Prev Chronic Dis; 2010 Jul; 7(4):A84. PubMed ID: 20550842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer surveillance using registry data: Results and recommendations for the Lithuanian national prostate cancer early detection programme.
    Gondos A; Krilaviciute A; Smailyte G; Ulys A; Brenner H
    Eur J Cancer; 2015 Aug; 51(12):1630-7. PubMed ID: 26044924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.